Search
-
News
Read about how Hedvig Hricak and Lawrence Dauer have been helping the National Aeronautics and Space Administration (NASA) break down an extraterrestrial "glass ceiling."
… Thursday, July 15, 2021 Hedvig Hricak and Lawrence Dauer have been helping the National Aeronautics and Space Administration (NASA) break down an extraterrestrial “glass ceiling.” The Memorial Sloan Kettering radiation experts were contributors to a https://www.nap.edu/read/26155/chapter/1 new report
-
News
Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to the first City & State Life Sciences Power 50.
… Tuesday, August 3, 2021 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to the first City & State Life Sciences Power 50 . The list recognizes the most notable individuals who are making strides in the life sciences in New York, including leaders
-
News
Get helpful advice on being a caregiver for someone with cancer.
… Thursday, August 19, 2021 Cancer caregivers wear many hats: chauffer, secretary, chef, cheerleader, and more. It’s no wonder the position can feel overwhelming. “It’s a role you never applied for and probably never trained for either,” says Diane Reidy-Lagunes, a medical oncologist at Memorial Sloan
-
News
Memorial Sloan Kettering Cancer Center (MSK) has appointed Atefeh “Atti” Riazi as Chief Information Officer (CIO). In this role, Ms. Riazi will develop and implement an enterprise-wide, long-term strategic information technology (IT) plan and oversee the integration of data and technology resources across the organization.
… Thursday, January 30, 2020 Atefeh Riazi Atefeh Riazi Memorial Sloan Kettering Cancer Center (MSK) has appointed Atefeh “Atti” Riazi as Chief Information Officer (CIO), effective February 3. In this role, Ms. Riazi will develop and implement an enterprise-wide, long-term strategic information technology
-
News
Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance. Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative initiative that aims to improve the quality of care and outcomes for people with cancer in community settings.
… Thursday, January 26, 2017 Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance . Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative
-
News
Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.
… Thursday, July 23, 2020 Summary Scientists at the Sloan Kettering Institute , the Koch Institute at MIT , and the Klarman Cell Observatory at the Broad Institute have identified an unusual cell state that emerges early in tumor evolution and supports a cancer’s ability to outwit chemotherapy. Cancer’
-
News
A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal Cancer Cell, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.
… Thursday, June 24, 2010 A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. “Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients
-
News
When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.
… Monday, March 4, 2024 When Dennis Flaherty was told he had stage 4 kidney cancer in February 2021, the doctor who diagnosed him at a local hospital on Long Island suggested he get his affairs in order. But from the moment he learned he had cancer, Dennis knew he wanted to be treated at Memorial Sloan
-
News
PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the PSA test.
… Thursday, October 30, 2025 While the benefits of screening tests for cervical cancer , breast cancer , and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening tool for prostate cancer is the PSA test , which measures levels of a protein
-
News
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
… Thursday, January 4, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Omar Abdel-Wahab Received the William Dameshek Prize from the American Society of Hematology Omar Abdel-Wahab, MD , leukemia specialist, Chair of the Molecular Pharmacology at the